{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:20:40Z","timestamp":1648740040612},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T00:00:00Z","timestamp":1481673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.rgmx.2016.09.001","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T16:45:26Z","timestamp":1488905126000},"page":"106-114","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Factores de riesgo asociados a reca\u00edda de enfermedad por reflujo gastroesof\u00e1gico en pacientes de primer nivel de atenci\u00f3n exitosamente tratados con inhibidor de la bomba de protones"],"prefix":"10.1016","volume":"82","author":[{"given":"A.","family":"L\u00f3pez-Colombo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Pacio-Quiterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.Y.","family":"Jes\u00fas-Mejenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.G.","family":"Rodr\u00edguez-Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"L\u00f3pez-Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Montiel-Jarqu\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"L\u00f3pez-Alvarenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.R.","family":"Morales-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.R.","family":"Ortiz-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"\u00c1vila-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2016.09.001_bib0135","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastro esophageal reflux disease: A global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2005.02368.x","article-title":"A randomized comparative study of esomeprazole 40mg versus pantoprazole 40mg for healing erosive oesophagitis: The EXPO study","volume":"21","author":"Labenz","year":"2005","journal-title":"Aliment Pharmacol The."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0145","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cgh.2014.09.033","article-title":"Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis","volume":"13","author":"Hsu","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0150","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1157\/13101167","article-title":"Influencia del estilo de vida en la enfermedad por reflujo gastroesof\u00e1gico","volume":"128","author":"Bujanda","year":"2007","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0155","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00535-010-0276-7","article-title":"Maintenance Study Group. Risk factors for relapse of erosive GERD during long-term maintenance treatment with proton pump inhibitor: A prospective multicenter study in Japan","volume":"45","author":"Fujimoto","year":"2010","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12664-012-0206-0","article-title":"Ingestion of a carbonated beverage decreases lower esophageal sphincter pressure and increases frequency of transient lower esophageal sphincter relaxation in normal subjects","volume":"31","author":"Shukla","year":"2012","journal-title":"Indian J Gastroenterol."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ajg.2015.18","article-title":"Risk factors on the development of new onset gastroesophageal reflux symptoms. A population based prospective cohort study: The HUNT study","volume":"110","author":"Hallan","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0170","first-page":"751","article-title":"Risk factors and prescription patterns of gastroesophageal reflux disease: HEAL study in Pakistan","volume":"64","author":"Butt","year":"2014","journal-title":"J Pak Med Assoc."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0175","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-230X-14-144","article-title":"Dietary guideline adherence for gastroesophageal reflux disease","volume":"14","author":"Kubo","year":"2014","journal-title":"BMC Gastroenterology"},{"key":"10.1016\/j.rgmx.2016.09.001_bib0180","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archinte.166.9.965","article-title":"Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach","volume":"166","author":"Kaltenbach","year":"2006","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0185","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2016.09.001_bib0190","first-page":"16","article-title":"Utilidad diagn\u00f3stica del cuestionario de Carlsson Dent en la enfermedad por reflujo gastroesof\u00e1gico (ERGE)","volume":"69","author":"G\u00f3mez Escudero","year":"2004","journal-title":"Rev Gastroenterol Mex."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0195","unstructured":"Faculty Group Practice Quality Management Program University of Michigan. Gastroesophageal reflux disease guideline, 2013 [consultado 13 Jun 2016]. Disponible en: http:\/\/www.med.umich.edu\/1info\/FHP\/practiceguides\/gerd\/gerd.12.pdf"},{"key":"10.1016\/j.rgmx.2016.09.001_bib0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000079707","article-title":"Evaluation of GERD Symptoms during therapy. Part 1. Development of the new questionnaire ReQuest in erosiveTM GERD","volume":"69","author":"Bardhan","year":"2004","journal-title":"Digestion."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3164\/jcbn.14-144","article-title":"Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: The first multicenter prospective study in Japan","volume":"57","author":"Mizuno","year":"2015","journal-title":"J Clin Biochem Nutr."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0210","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/00365521.2012.746395","article-title":"Systematic review: Symptoms of rebound acid hypersecretion following proton pump inhibitor treatment","volume":"48","author":"Lodrup","year":"2013","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0215","article-title":"Medical treatments in the short term management of reflux oesophagitis","author":"Khan","year":"2007","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0220","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003245.pub3","article-title":"WITHDRAWN: Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease","author":"Donnellan","year":"2010","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0225","first-page":"CD002095","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","volume":"5","author":"Sigterman","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0230","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","article-title":"Updated guidelines for diagnosis and treatment of gastroesophageal reflux disease","volume":"100","author":"DeVault","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2016.09.001_bib0235","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2982.2012.01888.x","article-title":"PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: A meta-analysis","volume":"24","author":"Weijenborg","year":"2012","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0240","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2036.2010.04232.x","article-title":"Systematic review: The effects of carbonated beverages on gastro-oesophageal reflux disease","volume":"31","author":"Johnson","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0245","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10620-014-3349-2","article-title":"Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus","volume":"60","author":"Schneider","year":"2015","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3810\/pgm.2014.01.2728","article-title":"Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus","volume":"126","author":"Peura","year":"2014","journal-title":"Postgrad Med."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0255","first-page":"1147","article-title":"Mucosal protective drugs","volume":"73","author":"Sugiyama","year":"2015","journal-title":"Nihon Rinsho."},{"key":"10.1016\/j.rgmx.2016.09.001_bib0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/2040622315569501","article-title":"Lifestyle measures in the management of gastro-oesophageal reflux disease: Clinical and pathophysiological considerations","volume":"6","author":"Kang","year":"2015","journal-title":"Ther Adv Chronic Dis."}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090616300921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090616300921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T19:50:21Z","timestamp":1536004221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0375090616300921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0375090616300921"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2016.09.001","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factores de riesgo asociados a reca\u00edda de enfermedad por reflujo gastroesof\u00e1gico en pacientes de primer nivel de atenci\u00f3n exitosamente tratados con inhibidor de la bomba de protones","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}